Among these genes, high expression of PXN, ELK1, ARHGEF19, DCBLD1, IKBKB, and CSF1 significantly predicted shorter survival in RCC patients according to The Cancer Genome Atlas (TCGA) analyses (p < 0.05). This evidence concerns the gene DCBLD1 and renal cell carcinoma.